NEWS AND UPDATES
IHS Expands Team to Market Insignis™ Syringe Infusion System after Receiving FDA Clearance
CHESTER, N.Y., Aug. 5, 2024 /PRNewswire/ -- Innovative Health Sciences ("IHS" or the "Company"), a medical device company that creates state-of-the-art drug infusion solutions, announced today the expansion of its commercialization team to market the Insignis™ Syringe...
Innovative Health Sciences Receives FDA Clearance for Insignis™ Subcutaneous Needle Sets
CHESTER, N.Y. (August 26, 2021) – Innovative Health Sciences, LLC (“IHS” or the “Company”) management announced today that IHS has received FDA clearance for its Insignis™ Subcutaneous Needle Sets. This regulatory clearance allows IHS to sell and distribute its...
Innovative Health Sciences to Showcase its State-of-the-Art Insignis™ Syringe Infusion System at Medica 2021
CHESTER, N.Y. (November 12, 2021) Innovative Health Sciences, LLC (“IHS” or the “Company”) will be presenting its breakthrough versatile and low cost non-electric infusion system at Medica, a world-renowned trade fair for medical devices and medical technologies,...